Page 8 - Azta News Today

Commonwealth Equity Services LLC purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTA – Get Rating) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 4,122 shares of the company’s stock, valued at approximately $297,000. Several other hedge funds and other […]

Azenta, Inc. (NASDAQ:AZTA – Get Rating) SVP Kimberly Crowley sold 132 shares of the stock in a transaction that occurred on Tuesday, April 12th. The shares were sold at an average price of $78.02, for a total value of $10,298.64. Following the transaction, the senior vice president now owns 5,133 shares of the company’s stock, […]

Azenta (NASDAQ:AZTA – Get Rating) issued an update on its third quarter 2022 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $0.09-$0.17 for the period, compared to the consensus estimate of $0.18. The company issued revenue guidance of $140.00 million-$150.00 million, compared to the consensus revenue estimate of $150.38 […]

Azenta (NASDAQ:AZTA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Monday, Zacks.com reports. According to Zacks, “Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as […]

Azenta, Inc. (NASDAQ:AZTA – Get Rating) – Analysts at B. Riley cut their Q3 2022 earnings per share (EPS) estimates for shares of Azenta in a research note issued on Tuesday, May 17th. B. Riley analyst Y. Zhi now expects that the company will post earnings of $0.07 per share for the quarter, down from […]

Azenta (NASDAQ:AZTA – Get Rating) updated its third quarter earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $0.09-0.17 for the period, compared to the consensus estimate of $0.18. The company issued revenue guidance of $140-150 million, compared to the consensus revenue estimate of $150.40 million.Azenta also updated its Q3 2022 […]

Analysts expect that Azenta, Inc. (NASDAQ:AZTA – Get Rating) will post $141.73 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Azenta’s earnings, with the lowest sales estimate coming in at $140.58 million and the highest estimate coming in at $142.60 million. Azenta reported sales of $286.59 […]

Azenta (NASDAQ:AZTA – Get Rating) and Katy Industries (OTCMKTS:KATYQ – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Institutional & Insider Ownership 92.9% of Azenta shares are owned by […]

Azenta (NASDAQ:AZTA – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas […]

Wall Street analysts expect that Azenta, Inc. (NASDAQ:AZTA – Get Rating) will announce earnings per share (EPS) of $0.11 for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Azenta’s earnings. The lowest EPS estimate is $0.10 and the highest is $0.12. Azenta reported earnings per share of $0.69 during the same […]